Sensitization to insulin induced by β,β'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo

Diabetes

Volumn 46, Issue 12, 1997, Pages 1958-1964

  Mayorek, Nina ^a   Kalderon, Bella ^a   Itach, Etty ^a   Bar Tana, Jacob ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; FATTY ACID BLOOD LEVEL; GLUCOSE METABOLISM; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0030773514     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.12.1958     Document Type: Article

References (38)

1. McGarry JD: Disordered metabolism in diabetes: have we underemphasized the fat cell component? J Cell Biochem 555:29-38, 1994
2. Randle PJ, Hales CN, Caarland PB, Newsholme EA: The glucose fatty acid cycle: its role in insulin insensitivity and metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
3. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10,1997
4. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991
5. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW: Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid. Diabetes 40:280-289, 1991
6. Bar-Tana J, Rose-Kahn G, Srebnik B: Inhibition of lipid synthesis by β,β + ′ tetramethyl-substituted C14-C22 or, dicarboxylic acids in the rat in vivo. J Biol Chem 260:8404-8410, 1985
7. Bar-Tana J, Rose-Kahn G, Frenkel B, Shafer Z, Fainaru M: The hypolipidemic effect of β,β + ′-methyl-substituted hexadecanedioic acid in normal and nephrotic rats. J Lipid Res 29:431-441, 1988
8. Russel JC, Dolphin PJ, Hameed M, Stewart B, Koeslag DG, Rose-Kahn G, Bar-Tana J: The hypolipidemic effect of β,β + ′-tetramethylhexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats. Arterioscler Thromb 11:602-609, 1991
9. Frenkel B, Mayorek N, Hertz R, Bar-Tana J: The hypochylomicronemic effect of β,β + ′-methyl-substituted hexadecanedioic acid is mediated by a decrease in apolipoprotein C-III. J Biol Chem 263:8491-8497, 1988
10. Frenkel B, Bishara-Shieban J, Bar-Tana J: The effect of β,β + ′-methyl-substituted hexadecanedioic acid on plasma VLDL metabolism in rats: role of apolipoprotein C-III. Biochem J 298:409-414, 1994
11. Hertz R, Bishara-Shieban J, Bar-Tana J: Mode of action of peroxisome proliferators as hypolipidemic drugs: suppression of apolipoprotein C-III. J Biol Chem 270:13470-13475, 1995
12. Kalderon B, Hertz R, Bar-Tana J: Tissue selective modulation of redox and phosphate potentials by β,β + ′-methyl-substituted hexadecanedioic acid. Endocrinology 131:1629-1635, 1992
13. Tzur R, Smith E, Bar-Tana J: Adipose reduction by β,β + ′-tetramethyl-substituted hexadecanedioic acid (MEDICA 16). Int J Obesity 13:313-326, 1989
14. Rose-Kahn G, Bar-Tana J: Inhibition of lipid synthesis by β,β + ′ tetramethyl-substituted C14-C22a, dicarboxylic acids in cultured rat hepatocytes. J Biol Chem 260:8411-8415, 1985
15. Hertz R, Aurbach R, Hashimoto T, Bar-Tana J: Thyromimetic effect of peroxisomal proliferators in rat liver. Biochem J 274:745-751, 1991
16. Hertz R, Ben-Ishai A, Nikodem V, Berman I, Bar-Tana J: Thyromimetic mode of action of peroxisome proliferators: transcriptional activation of liver malic enzyme. Biochem J 319:241-248, 1996
17. Tzur R, Rose-Kahn G, Adler JH, Bar-Tana J: Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of β,β + ′-methyl-substituted hexadecanedioic acid in sand rats. Diabetes 37:1618-1624, 1988
18. Bar-Tana J, Ben-Shoshan S, Blum J, Migron Y, Hertz R, Pill J, Rose-Kahn G, Witte C: Synthesis, hypolipidemic and antidiabetogenic activities of β,β + ′-tetra-substituted, long chain dioic acids. J Med Chem 32:2072-2084, 1989
19. Russel JC, Amy RM, Graham SE, Dolphin PJ, Bar-Tana J: Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β,β + ′-tetramethyl hexadecanedioic acid. Arterioscler Thromb Vase Biol 15:918-923, 1995
20. Bhanot S, Bryer-Ash M, Cheung A, McNeill JH: Bis(maltolato)oxovanadium(IV) attenuates hyperinsulinemia and hypertension in spontaneously hypertensive rats. Diabetes 43:857-861, 1994
21. 18O dilution. Am J Clin Nutr 35:591-594, 1982
22. Klein S, Young VR, Blackburn GL, Bistrian BR, Wolfe RR: Palmitate and glycerol kinetics during brief starvation in normal weight young adults and elderly subjects. J Clin Invest 78:928-933, 1986
23. Bougneres PF, Bier DM: Stable isotope dilution method for measurement of palmitate content and labeled palmitate tracer enrichment in microliter plasma samples. J Lipid Res 23:502-507, 1982
24. 9-tetrabydro-cannabinol in uríne as its t-butyldimethylsilyl derivative using GC/MS. J Analyt Toxicol 17:1-4, 1993
25. Weidenfeld J, Corcos AP, Wohlman A, Feldman S: Characterization of the 2-deoxyglucose effect on the adrenocortical axis. Endocrinology 134:1924-1931, 1994
26. Steele R, Wall JS, de Bodo RC, Altszuler N: Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15-24, 1956
27. Bier DM, Arnold KJ, Sherman WR, Holland WH, Holmes WF, Kipnis DM: In vivo measurement of glucose and alanine metabolism with stable isotopic tracers. Diabetes 26:1005-1015, 1977
28. Wolfe RR, Klein S, Carraro F, Weber JM: Role of triglyceride: fatty acid cycling in controlling fat metabolism in humans during and after exercise. Am J Physiol 258:E382-E389, 199020
29. Campbel PJ, Carlson MG, Hill OJ, Nurjhan N: Regulation of free fatty acid metabolism by insulin in human: role of lipolysis and reesterification. Am J Physiol 263:E1063-E1069, 1992
30. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogeneous glucose infusates. Diabetes 36:914-924, 1987
31. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
32. Wolfe RR, Durkot MJ: Role of very low density lipoproteins in the energy metabolism of the rat. J Lipid Res 26:210-217, 1985
33. Terrettaz F, Assimacopoulos-Jeannet F, Jeanrenaud B: Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. Endocrinology 118:674-678, 1986
34. Pénicaud L, Ferré P, Terretaz J, Kinebanyan MF, Leturque A, Doré E, Girard J, Jeanrenaud B, Picon L: Development of obesity in Zucker rats: early insulin resistance in muscles but normal sensitivity in white adipose tissue. Diabetes 36:626-631, 1987
35. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863-870, 1995
36. Cleary MP, Vasselli JR, Greenwood MRC: Development of obesity in Zucker obese (fa/fa) rat in absence of hyperphagia. Am J Physiol 238:E284-E292, 1980
37. Tataranni PA, Baier LJ, Howard BV, Ravussin E: Role of lipids in development of noninsulin-dependent diabetes mellitus: lessons learned from Pima Indians. Lipids 31:S267-S270, 1996
38. Bowen L, Stein PP, Stevenson R, Shulman GI: The effect of CP 68,722, a thiazolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats. Metabolism 40:1025-1030, 1991